Current price is more than the intrinsic value
Stock has been generating better return on equity than bank FD
Insufficient Data
Good time to consider, as stock is not in overbought zone
Stock not in ASM/GSM lists and not a lot of promoter holding is pledged
—
—
—
Supriya Lifescience is a manufacturer of pharmaceutical preparation.
Customise key metrics, see detailed forecasts, download stock data and more
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has almost stayed constant
Pursuant to the relevant provisions of the SEBI Listing Regulations, we would like to inform you that the officials of our Company, Supriya Lifescience Limited (¬タワCompany¬タン) will be interacting with Analyst/Institutional Investors on July 5, 2022 via video conference.This is to further inform that the copy of the Investor Presentation has been uploaded on the Stock Exchanges and on the Company¬タルs website www.supriyalifescience.com for your information and for the information of your members and the public at large.This information is submitted to you pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015.Note: The above date is subject to change. Change may happen due to exigencies on the part of Company or Analyst/Investor/Fund.Request you to kindly take the same on record. | Download
Pursuant to the relevant provisions of the SEBI Listing Regulations, we would like to inform you that the officials of our Company, Supriya Lifescience Limited (¬タワCompany¬タン) will be interacting with Analyst/Institutional Investors on July 5, 2022 via video conference.This is to further inform that the copy of the Investor Presentation has been uploaded on the Stock Exchanges and on the Company¬タルs website www.supriyalifescience.com for your information and for the information of your members and the public at large.This information is submitted to you pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015.Note: The above date is subject to change. Change may happen due to exigencies on the part of Company or Analyst/Investor/Fund.Request you to kindly take the same on record. | Download
Pursuant to the relevant provisions of the SEBI Listing Regulations, we would like to inform you that the officials of our Company, Supriya Lifescience Limited (¬タワCompany¬タン) will be interacting with Analyst/Institutional Investors on July 1, 2022 via video conference.This is to further inform that the copy of the Investor Presentation has been uploaded on the Stock Exchanges and on the Company¬タルs website www.supriyalifescience.com for your information and for the information of your members and the public at large.This information is submitted to you pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015.Note: The above date is subject to change. Change may happen due to exigencies on the part of Company or Analyst/Investor/Fund.Request you to kindly take the same on record. | Download
Pursuant to the relevant provisions of the SEBI Listing Regulations, we would like to inform you that the officials of our Company, Supriya Lifescience Limited (¬タワCompany¬タン) will be interacting with Analyst/Institutional Investors on July 1, 2022 via video conference.This is to further inform that the copy of the Investor Presentation has been uploaded on the Stock Exchanges and on the Company¬タルs website www.supriyalifescience.com for your information and for the information of your members and the public at large.This information is submitted to you pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015.Note: The above date is subject to change. Change may happen due to exigencies on the part of Company or Analyst/Investor/Fund.Request you to kindly take the same on record. | Download
Supriya Lifescience Limited has informed the Exchange about Schedule of Analysts/Institutional Investor Meet/Con. Call Pursuant to the relevant provisions of the SEBI Listing Regulations, we would like to inform you that the officials of our Company, Supriya Lifescience Limited (¬タワCompany¬タン) will be interacting with Analyst/Institutional Investors on June 30, 2022 via video conference.This is to further inform that the copy of the Investor Presentation has been uploaded on the Stock Exchanges and on the Company¬タルs website www.supriyalifescience.com for your information and for the information of your members and the public at large.This information is submitted to you pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015.Note: The above date is subject to change. Change may happen due to exigencies on the part of Company or Analyst/Investor/Fund.Request you to kindly take the same on record. | Download
Supriya Lifescience Limited has informed the Exchange about Schedule of Analysts/Institutional Investor Meet/Con. Call Pursuant to the relevant provisions of the SEBI Listing Regulations, we would like to inform you that the officials of our Company, Supriya Lifescience Limited (¬タワCompany¬タン) will be interacting with Analyst/Institutional Investors on June 30, 2022 via video conference.This is to further inform that the copy of the Investor Presentation has been uploaded on the Stock Exchanges and on the Company¬タルs website www.supriyalifescience.com for your information and for the information of your members and the public at large.This information is submitted to you pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015.Note: The above date is subject to change. Change may happen due to exigencies on the part of Company or Analyst/Investor/Fund.Request you to kindly take the same on record. | Download
Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa
Current price is more than the intrinsic value